首页> 外文期刊>Neuroepidemiology >Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study.
【24h】

Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study.

机译:老年痴呆症的发病率:临床,神经病理学和分子遗传学研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aims: To evaluate the effect of medical record use on figures for the incidence of dementia and the effect of apolipoprotein E (APOE) polymorphism on this incidence and neuropathologically defined Alzheimer's disease (AD) in very elderly individuals. Methods: Cognitive functions were examined in a cohort of 328 (92% of the very elderly people of a town participated in this study) nondemented Finnish elderly individuals 85 years of age or more in 1991. The examination was repeated in survivors in 1994, 1996, 1999 and 2001. Medical notes and social work records were evaluated. All these individuals were genotyped for APOE. Neuropathological analysis of AD-type pathology was performed on 159 of 303 subjects who died during the follow-up. Results: Age group, gender or APOE did not significantly affect the incidence of dementia, which was over 20% higher (85 vs. 69 per 1,000 person-years) if the cognitive status at death was ascertained by medical and social work records than without this evaluation. The APOE upsilon4 allele was highly significantly (p = 0.002) and age almost significantly (p = 0.06) associated with neuropathological AD in nondemented individuals. Conclusions: Medical records should be analyzed in studies on the incidence of dementia in very elderly individuals. APOE polymorphism does not affect the incidence of dementia in this age group. However, clinical dementia diagnosis in very elderly individuals does not necessarily correlate well with the presence of neuropathological AD which, even in this age group, is significantly associated with the APOE upsilon4 allele. Copyright (c) 2006 S. Karger AG, Basel.
机译:目的:评估老年患者中病历使用数字对痴呆症发病率的影响以及载脂蛋白E(APOE)多态性对该发病率和神经病理学定义的阿尔茨海默氏病(AD)的影响。方法:在1991年对328名年龄在85岁或以上的芬兰痴呆老年人进行了328个队列研究(该镇的92%的极高老年人参加了这项研究)。1994年,1996年在幸存者中重复进行了这项检查,1999年和2001年。对医疗记录和社会工作记录进行了评估。对所有这些个体进行APOE基因分型。对303名在随访中死亡的受试者中的159名进行了AD型病理的神经病理学分析。结果:年龄组,性别或APOE对痴呆症的发病率没有显着影响,如果通过医学和社会工作记录确定死亡时的认知状态,则痴呆症的发病率比未患痴呆症的发病率高出20%以上(85比69,每千人年)。这个评价。在非痴呆个体中,与神经病理性AD相关的APOE upsilon4等位基因高度显着(p = 0.002),年龄几乎显着(p = 0.06)。结论:关于老年患者痴呆发生率的研究应分析病历。 APOE基因多态性不会影响该年龄段痴呆的发生率。然而,非常年长的个体的临床痴呆诊断不一定与神经病理性AD的存在有很好的相关性,即使在这个年龄组中,其也与APOE upsilon4等位基因显着相关。版权所有(c)2006 S. Karger AG,巴塞尔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号